Effects of Subcostal Anterior Quadratus Lumborum Block with and without Dexmedetomidine on Postoperative Rehabilitation in Patients Undergoing Laparoscopic Renal Surgery: A Prospective Double-Blinded Randomized Controlled Study

Drug Des Devel Ther. 2023 Nov 10:17:3281-3293. doi: 10.2147/DDDT.S422356. eCollection 2023.

Abstract

Background: The combination of different anesthesia techniques or adjuvant drugs can relieve the stress response to surgery, reduce adverse reactions and improve the clinical outcome. We investigated the effects of subcostal anterior quadratus lumborum block (SQLB) with and without dexmedetomidine (DEX) on postoperative rehabilitation for laparoscopic renal surgery (LRS).

Methods: We included 90 patients in this single-center study. All were scheduled for elective laparoscopic radical or partial nephrectomy under general anesthesia (GA). We randomly and evenly assigned them to three groups: Group GA (GA alone), Group QG (SQLB with 30 mL of 0.25% ropivacaine and GA), and Group DQG (SQLB with 30 mL of 0.25% ropivacaine plus 1 μg/kg DEX and GA). The primary outcomes were serum creatinine (Cr) and blood urea nitrogen (BUN) levels; the secondary outcomes included the average numeric rating scale (NRS) scores at rest and during activity within 48 h postoperatively; perioperative opioid consumption; the time to first ambulation, exhaust, and fluid intake, and postoperative adverse reactions.

Results: The serum Cr and BUN levels in Group DQG decreased significantly compared with Group GA (P < 0.05). The average NRS scores in Group DQG were significantly lower than other two groups (P < 0.05). Furthermore, the indexes reduced significantly in Group QG compared with Group GA (P < 0.05). Groups DQG and QG had lower consumption of opioid compared with Group GA (P < 0.05). The recovery indicators in Groups DQG and QG were higher quality than Group GA (P < 0.05). The incidences of adverse reactions in Group DQG was significantly lower than the other groups (P < 0.05).

Conclusion: SQLB with and without DEX could attenuate postoperative pain, reduce opioids requirement and side effects, as well as facilitate postoperative early rehabilitation. More interesting, SQLB with DEX could confer kidney protection.

Clinical trial registration number: The Chinese Clinical Trial Registry (ChiCTR2200061554).

Keywords: dexmedetomidine; laparoscopic renal surgery; renal function; subcostal anterior quadratus lumborum block.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Anesthetics, Local / therapeutic use
  • Dexmedetomidine* / therapeutic use
  • Humans
  • Kidney / surgery
  • Laparoscopy* / adverse effects
  • Pain, Postoperative / drug therapy
  • Pain, Postoperative / prevention & control
  • Prospective Studies
  • Ropivacaine / therapeutic use

Substances

  • Ropivacaine
  • Dexmedetomidine
  • Analgesics, Opioid
  • Anesthetics, Local

Grants and funding

This work was supported by the Horizontal funding of Shandong University (No.6010220014).